FDA On Track To Beat ANDA Performance Goal In 2001, OGD's Buehler Says
This article was originally published in The Tan Sheet
Executive Summary
FDA is likely to beat its ANDA productivity target for 2001, Office of Generic Drugs Acting Director Gary Buehler told a regulatory workshop sponsored by FDA and the Generic Pharmaceutical Association in Bethesda, Md. May 21.